Citius Pharmaceuticals, Inc.
CTXR
$0.77
-$0.06-6.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.22M | -7.96M | -8.79M | -10.92M | -9.77M |
| Total Depreciation and Amortization | 557.00K | 62.00K | 41.40K | 56.00K | 54.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.55M | 2.40M | 2.57M | 2.37M | 2.28M |
| Change in Net Operating Assets | -8.89M | -6.38M | 772.00K | 3.95M | 2.71M |
| Cash from Operations | -13.01M | -11.88M | -5.41M | -4.54M | -4.73M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.40M | -5.75M | -- | -- | -- |
| Cash from Investing | -4.40M | -5.75M | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 1.30M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -300.00K | -- | -- |
| Issuance of Common Stock | 20.88M | 15.79M | 10.47M | 3.47M | 2.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 100.00 | 100.00 | -- | -- |
| Repurchase of Preferred Stock | -- | -100.00 | -100.00 | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.88M | 15.79M | 11.47M | 3.47M | 2.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.47M | -1.84M | 6.06M | -1.07M | -2.15M |